Scientometrics and Drawing of Structure and Scientific Maps Related to the “International Technology Commercializationin Pharmaceutical Industry and Biological Products”

Document Type : مقالات علمی پژوهشی

Authors
M. Kavei 1
H. Sadeghi 2
M. azizi 3
1 in Entrepreneurship, Islamic Azad University, Qazvin Branch, Department of Entrepreneurship, Qazvin, Iran
2 Department of Business, Faculty of Entrepreneurship,University of Tehran,Tehran, Iran
3 Department of Entrepreneurship, Faculty of Entrepreneurship, University of Tehran, Tehran, Iran
Abstract
With regard to the transformation of the pharmaceutical industry in coordination with biotechnological achievements and the importance of biopharmaceuticals for the treatment of rare diseases in societies, the study on the commercialization process has an important role in quick delivery of drugs to the market. The aim of this study is to draw a plan for technology commercialization focusing on pharmaceutical industry and biological products. The statistical population includes all scientific documents in the above field that were indexed in the "Scopus" database until 2019. This study is conducted using Scientometrics approach, vocabulary synchronization and content analysis of documents. In the process, research questionnaire was designed based on related strings- commercialization models, pharmaceutical industry – and was taken from valid databases. The results of this study show that in these two fields, various researches have been conducted independently, but little attention has been paid to the issue of international technology commercialization in pharmaceutical industry.

Keywords

Subjects

1) افتخاری، حسین. عابدی فر، وحید. جدا، رقیه. سجودی سردرود، پروین. محمدی، لیلا. 1397. بکارگیری روش تحلیل هم‌رخدادی واژگان برای تجزیه‌وتحلیل نسل پنجم شبکه‌های ارتباطی (5G). هشتمین کنفرانس بین المللی توسعه پایدار، عمران و بازآفرینی شهری.
2) پناهی، عبدالعظیم. مومنی، عزت. اکبری، محمد. کمال نژاد. عالیه. 1395. تحلیل تطبیقی استنادهای پایان نامه‌های دکتری روانشناسی عمومی دانشگاه‌های علامه طباطبایی و تربیت مدرس. پژوهشنامه علم سنجی. دوره 2. شماره 1.
3) مصطفوی، اسماعیل. کیانی، حمیدرضا. 1394. ارزیابی تطبیقی کشورهای اسلامی پیشرو در تولید علم: مطالعه ایران، ترکیه، مصر و پاکستان در پایگاه اطلاعات علمی ESI. پژوهشنامه علم سنجی. دوره 1. شماره 1.
4) نوروزی چاکلی، عبدالرضا. حسن زاده، محمد. 1389. توسعه علم، فناوری و نوآوری؛ رهیافت شاخص‌های علم‌سنجی. مدیریت اطلاعات سلامت. دوره ۷. شماره ۴.
منابع لاتین
5) Cooper, R. G. (1994). Perspective third generation new product processes. Journal of Product Innovation Management. Vol. 11, pp.3-14.
6) Charttirot, K. Natcha, T. and Achara, C. (2014). Evaluation model for research and development commercialization capability.
7) Dai, Y. Gurau, C. & Ranchhod, A. (2006). Open innovation in the UK biopharmaceutical industry. 8th session on: Innovation in the extended enterprise. July 5th-8th, Brindisi, Ital 3-6.
8) Daly, P. (1985). The Biotechnology Business: A Strategic Analysis. London: Francis Pinter.
9) Degeeter, M.J. (2004). Technology commercialization manual: strategy, tactics and economics for business success [online].
10) Diane, A. I. (2004). S&T Commercialization of Federal Research Laborites and University Research, Carleton University, Eric Sport School of Business, Canada.
11) EFPIA. 2011. Code of practice on relationships between the pharmaceutical industry and patient organisation. The European federation of pharmaceutical Industries and Associations. 4-8.
12) Edgett, S. J. (1996). The new product development process for Commercial financial services. Industrial Marketing Mangement, Vol. 23. pp. 507-515.
13) Ferguson, G. (2008). Commercialisation Models – a review of the literature on existing commercialisation models. Rumour Control Consultancy, Available at: http://rumourcontrol.com.au/?page_id=40.
14) Finfgeld, D. L. (2003). Meta synthesis: The state of the art—so far. Qualitative Health Research, 13: 893-904.
15) Gibson, M. (2009). Pharmaceutical Preformulation and Formulation. By Informa Healthcare USA, Inc: 245-48.
16) Goldsmith, R. (2003). Model of Commercialization. available online at: http:// asbdc.ualr.edu/technology/commercialization/the_model.asp.
17) Göktepe, D. (2004). Investigation of University Industry Technology Transfer Cases: A Conceptual and Methodological Approach, Division of Innovation-LTH Lund University
18) Goudarzi, M. (2012). Technology commercialization model of iranian governmental research institutions. Tehran: s.n.
19) Industry Canada (2006). People and Excellence: the Heart of Successful Commercialization- Volume II, Supporting Material. People and Excellence: The Heart of Successful Commercialization. Ottawa, Industry Canada.
20) King, J. (1987). A review of bibliometric and other science indicators and their role in research evaluation. ‎Journal of Information Science, 13 (5), 261–276.‎
21) Lemmetyinen, uha. (2001). Commercialization of biopharmaceuticals, master’s thesis submitted in partial fulfillment of the requirements for the degree of Master of Science in Economics, Lappeenranta University of technology. Helsinki.125-27.
22) Magnus, K. (2004). commercialization of research results in the united states, ITPS, Swedish Institute for growth policy studies, P.14,15, Accessed in www.itps.se.
23) Mehta, S. S. (2008). Commercializing successful biomedical technologies: basic principles for the development of drugs, diagnostics and devices. Cambridge University Press. 42-3.
24) Mahmodpoor B. et al. (2011). Identification of commercialization challenges of humanities researches and presentation a grounded theory. Journal of Innovation and Creativity in Human Science, No. 2, pp. 19-48, [in Persian].
25) Minseo, K. Hyesu, P. Yeong-wha, S. and Sun-young, P. (2019). bridging the Gap in the Technology Commercialization Process: Using a Three-Stage Technology–Product–Market Model Department of Management of Technology, School of Business, Konkuk University, 05029 Seoul, Korea;mskim.konkuk@gmail.com (M.K.); hsmot@konkuk.ac.kr (H.P.); sawng@konkuk.ac.kr (Y.-w.S.).
26) Nassiri-Koopaei, N. Majdzadeh, R. (2014). Commercialization of biopharmaceutical knowledge in Iran; challenges and solutions. DARU Journal of Pharmaceutical Sciences. 22:29.
27) Porter, M. (2011). Value Chain model framework, value Based Management. Retrieved 12-5-2013 from: http://www.valuebasedmanagement.net/methods_porter_value_chain.html.
28) Reamer, A. & Others. (2003). Technology transfer and commercialization :their role in economic development. Economic development administration,U.S.department of commerce.
The Journal of Research in Humanities
Volume 28, Issue 4
January 2022
Pages 119-139